MediXall Group, Inc. (MDXL)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue 59.26 Thousand 14.99 Thousand - 2685.00 1858.00 22.23 Thousand
Cost of Revenue 3.19 Million 3.06 Million 2.53 Million 1.37 Million 1.71 Million 836.63
Gross Profit -3.13 Million -3.05 Million -2.53 Million -1.37 Million -1.7 Million 21.39 Thousand
Operating Expenses 59.26 Thousand 6.38 Million 5.93 Million 3.42 Million 2.89 Million 1.66 Million
Selling, General and Administrative Expenses 5.84 Million 6.39 Million 5.3 Million 3.42 Million 2.89 Million 1.66 Million
Research and Development Expenses 38.82 Thousand - - - - -
Other Expenses - -16.5 Thousand 623.58 Thousand 3.03 Million -391.09 Thousand 1.54 Billion
Cost and Expenses 6.59 Million 6.38 Million 5.93 Million 3.42 Million 2.89 Million 1.66 Million
Operating Income -6.54 Million -6.53 Million -5.93 Million -3.42 Million -2896.76 -1.64 Million
Interest Expense 271.11 Thousand - - - - -
Income Tax Expense - -165.71 Thousand -202.29 Thousand -101.91 Thousand -86.67 Thousand -
Earnings before Tax -6.83 Million -6.2 Million -5.93 Million -3.42 Million -2.98 Million -1.64 Million
Net Income -6.83 Million -6.03 Million -5.93 Million -3.42 Million -2.98 Million -1.64 Million
Earnings Per Share Basic -0.06 -0.06 -0.07 -0.05 -0.05 -0.03
Earnings Per Share Diluted -0.06 -0.06 -0.07 -0.05 -0.05 -0.03
Weighted Average Shares Outstanding 116.66 Million 104.2 Million 90.63 Million 74.13 Million 65.01 Million 54.84 Million
Weighted Average Shares Outstanding (Diluted) 116.66 Million 104.2 Million 90.63 Million 74.13 Million 65.01 Million 54.84 Million
Gross Margin -52.96 -203.50 - -510.65 -920.10 0.96
EBIT Margin -110.07 -435.35 - -1248.05 -1510.73 -73.67
Profit Margin -115.25 -402.46 - -1274.10 -1605.72 -73.81
EBITDA -6.52 Million -6.12 Million -5.92 Million -3.41 Million -2.89 Million -1.55 Million
Earnings Before Tax Margin -110.35 -435.61 - -1274.10 -1.56 -73.81

Income Statement Charts